AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bogdanoff who wrote (511)	8/19/1997 11:51:00 AM
From: MulhollandDrive	of 2173

>>My view is that they mishandled the news release, causing or at least contributing to the overreaction, and their clinical trial program is mishandled.<< I agree with you on both counts, but let me ask you, do you think after listening to Haugen that they will remedy the the protocol problem with the next trials? I had a phone interruption during the interview, so I didn't see the entire thing....thanks bp

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next